Abstract

IntroductionSodium–glucose cotransporter 2 (SGLT2) inhibitors are now recommended in guidelines for persons with type 2 diabetes mellitus (T2DM) and at risk of advanced kidney disease as part of the glucose-lowering...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Sodium-glucose co-transporter 2 inhibitors: strength of evidence for a cardio-renal-metabolic therapy.
Pankaj Arora ... Vibhu Parcha
European journal of heart failure | VOL. 23
Pankaj Arora, et. al.Pankaj Arora ... Vibhu Parcha
05 Apr 2021
Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center.
Motoko Tanaka ... Akira Yoshida
Journal of clinical medicine research | VOL. 11
Motoko Tanaka, et. al.Motoko Tanaka ... Akira Yoshida
01 Jan 2019
Sodium-glucose co-transporter 2 inhibitors for heart failure: clinical trial efficacy and clinical practice effectiveness.
Stephen J Greene ... Muhammad Shahzeb Khan
European journal of heart failure | VOL. 23
Stephen J Greene, et. al.Stephen J Greene ... Muhammad Shahzeb Khan
07 Apr 2021
Finerenone—A New Frontier in Renin-Angiotensin-Aldosterone System Inhibition in Diabetic Kidney Disease
Vikas S Sridhar ... David Z.I Cherney
American Journal of Kidney Diseases | VOL. 78
Vikas S Sridhar, et. al.Vikas S Sridhar ... David Z.I Cherney
19 Mar 2021
View more papers

More From: BMJ Open Diabetes Research & Care

Paper Title
Journal
Date
Author
Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes
Matteo Franchi ... Giovanni Corrao
BMJ Open Diabetes Research & Care | VOL. 12
Matteo Franchi, et. al.Matteo Franchi ... Giovanni Corrao
27 May 2024
Prospective associations between breast feeding, metabolic health, inflammation and bone density in women with prior gestational diabetes mellitus
Ines Hebeisen ... Jardena J Puder
BMJ Open Diabetes Research & Care | VOL. 12
Ines Hebeisen, et. al.Ines Hebeisen ... Jardena J Puder
21 May 2024
Enhancing equity in access to automated insulin delivery systems in an ethnically and socioeconomically diverse group of children with type 1 diabetes
John Pemberton ... Suma Uday
BMJ Open Diabetes Research & Care | VOL. 12
John Pemberton, et. al.John Pemberton ... Suma Uday
15 May 2024
Clinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review
Julio Rosenstock ... Simon R Heller
BMJ Open Diabetes Research & Care | VOL. 12
Julio Rosenstock, et. al.Julio Rosenstock ... Simon R Heller
14 May 2024
View more papers